Introduction Carbonaceous nanomaterials have demonstrated to be very attractive for the development of innovative electrochemical biosensors due to their unique properties [1,2]. The rational selection of the functionalizing agent of these nanostructures represents a very promising strategy to prepare tailor-made design of carbon nanostructures with specific properties [3]. This communication deals with the design of biosensors for the quantification of clinical relevance markers like hydrogen peroxide, ethanol, glucose and microRNA-21 based on the use of glassy carbon electrodes (GCE) modified with multiwalled carbon nanotubes (MWCNTs) non-covalently functionalized with avidin (Av), glucose oxidase (GOx), polyarginine (Polyarg) or concanavalin A (ConA); and gold surfaces (Au) modified with reduced graphene oxide (RGrO) covalently modified with chitosan. Experimental MWCNTs were modified with Av, ConA and Polyarg by ultrasonication for a given time: 0.50 mg/mL MWCNTs in 1.00 mgmL-1 Av + 2.00 mgmL-1 GOx (MWCNTs-Av-GOx); 1.50 mg/mL MWCNTs in 2.00 mg/mL ConA (MWCNTs-ConA) or 0.75 mg/mL MWCNTs in 1.00 mg/mL Polyarg (MWCNTs-Polyarg). GrO (0.50 mg/mL) was covalently functionalized with 1.00 mg/mLchitosan (CHIT) followed by chemical reduction (RGO-CHIT). The analytical platforms were obtained either by drop-coating the GCEs with the corresponding dispersion, MWCNTs-Av-GOx (GCE/MWCNTs-Av-GOx), MWCNTs-Polyarg (GCE/MWCNTs-Polyarg) and MWCNTs-ConA (GCE/MWCNTs-ConA) or by self-assembling of RGrO-CHIT at Au modified with 3-mercaptopropane sulfonate(MPS), (Au/MPS/RGrO-CHIT). Results and Conclusions The enzymatic biosensors were prepared by immobilization of: I) biotinylated horseradish peroxidase (biot-HRP) at GCE/MWCNTs-Av-GOx to develop an amperometric biosensor for the micromolar detection of glucose (linear range between 25 and 750 µM, sensitivity of (4.8 ± 0.3) µAmM-1 and a detection limit of 1.2 μM) with successful recovery percentages in a pharmaceutical product (Nasal spray “Allennys”, (2.7 ± 0.1) mg/dose vs a reported value of (2.75 mg/dose, and milk samples (“La Serenísima”), (2.1 ± 0.1) g mL-1 vs. the reported value of 1.9 gmL-1); II)Alcohol dehydrogenase at GCE/MWCNTs-Polyarg containing the NAD+ accumulated at the surface for the submicromolar amperometric detection of ethanol without needing of external enzymatic mediator (linear range between 5.0x10-6 and 1.0x10-4 M, sensitivity of (1487 ± 6) µA M-1, and a detection limit of 0.65 µM) with efficient applications in different alcoholic beverages; III) biotinylated GOx at GCE/MWCNTs-Av followed by the electrodeposition of Ru nanozyme to obtain a sensitive psuedobienzymatic amperometric glucose biosensor (linear range from 2.0 x 10-5 M to 1.23 x 10-3 M, sensitivity of (0.343 ± 0.002) µA mM-1, and a detection limit of 3.3 µM) with successful applications for the determination of glucose in different beverages (Gatorade®, Red bull® and Pepsi® samples); III) GOx and HRP at GCE/MWCNTs-ConA to build bienzymatic glucose biosensors through the site-specific anchoring of both glycoenzymes, HRP and GOx, for the amperometric detection of glucose at submicromolar concentrations with practical applications in a blood human serum with excellent correlation with the laboratory results ((0.84 ± 0.04) g/L vs the laboratory value of 0.87 g/L). The proposed arquitectures present the advantages that the functionalizing agents made possible not only the efficient exfoliation of the MWCNTs but also give to them special properties: Polyarg allowed the highly successful accumulation of NAD+ at the electrode surface eliminating the usual problem of incorporating the enzymatic mediator in the measurement solution, and avidin and concanavalin A worked as specific anchoring site of the biorecognition element. The association of MWCNTs-Av-biotGOx with the nanozyme Ru allowed to obtain an innovative hybrid material with improved properties compared to the individual components due to the combined properties and/or synergistic effect of the individual materials. The genosensor for the quantification of microRNA-21 was obtained by covalent attachment of NH2-DNA probe sequence at Au/MPS/RGrO-CHIT followed by the hybridization in phosphate buffer solution pH 7.40. The hybridization event was label-free detected using Electrochemical Impedance Spectroscopy from the charge transfer resistances of the redox indicator potassium ferrocyanide/potassium ferricyanide. Micro-RNA-21 was detected at picomolar levels, with successful recoveries in human blood serum, urine and saliva samples. The proposed MWCNTs-proteins dispersions represent an interesting and innovative alternative to build multifunctional nanoarquitectures for the development of different biosensors just by changing the biotinylated biomolecule in the case of GCE/MWCNTs-Av or the glycobiomolecule anchored at GCE/MWCNTs-ConA. The correct selection of the transduction scheme according to the graphenaceous material incorporated within the biosensor and the critical design of the biorecognition platform allowed the successful detection of microRNA-21, opening the doors to future biomarkers sensing development. References [1] K. Bala, D. Sharma, N. Gupta, ChemElectroChem. 6 (2019) 274-288. doi.org/10.1002/celc.201801319 [2]G.A. Rivas, M.C. Rodríguez, M.D. Rubianes, F.A. Gutierrez, M. Eguílaz, P.R. Dalmasso, E.N. Primo, C. Tettamanti, M.L. Ramírez, A. Montemerlo, P. Gallay, C. Parrado, Carbon nanotubes-based electrochemical (bio)sensors for biomarkers, Appl. Mater. Today. 9 (2017) 566–588. doi:10.1016/j.apmt.2017.10.005. [3] F. Gutierrez, M. D. Rubianes, G. A. Rivas, F. Gutierrez, M. D. Rubianes, G. A. Rivas, Anal. Chim. Acta, 1065 (2019) 1. doi.org/10.1016/j.aca.2019.03.022.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.